Special Enrollment Period Battle Continues As Stakeholders Comment On NBPP

October 25, 2016 at 1:02 PM
Issuers and beneficiary advocates remain miles apart when it comes to their views on special enrollment periods (SEPs), with issuers urging CMS to immediately implement a broad pre-enrollment plan and advocates saying more data on the impact of SEPs is needed before CMS takes further action to restrict them. The agency in its draft 2018 Notice of Benefit and Payment Parameters proposed to codify earlier changes to SEPs. The agency also sought comments and data that “could help distinguish misuse...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.